IRIS Accounts Production v24.2.0.383 08839219 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh088392192023-01-31088392192024-01-31088392192023-02-012024-01-31088392192022-01-31088392192022-02-012023-01-31088392192023-01-3108839219ns15:EnglandWales2023-02-012024-01-3108839219ns14:PoundSterling2023-02-012024-01-3108839219ns10:Director12023-02-012024-01-3108839219ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3108839219ns10:SmallEntities2023-02-012024-01-3108839219ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3108839219ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3108839219ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3108839219ns10:FullAccounts2023-02-012024-01-3108839219ns10:OrdinaryShareClass12023-02-012024-01-3108839219ns10:Director22023-02-012024-01-3108839219ns10:RegisteredOffice2023-02-012024-01-3108839219ns5:CurrentFinancialInstruments2024-01-3108839219ns5:CurrentFinancialInstruments2023-01-3108839219ns5:ShareCapital2024-01-3108839219ns5:ShareCapital2023-01-3108839219ns5:RetainedEarningsAccumulatedLosses2024-01-3108839219ns5:RetainedEarningsAccumulatedLosses2023-01-3108839219ns5:LongLeaseholdAssetsns5:LandBuildings2023-02-012024-01-3108839219ns5:ComputerEquipment2023-02-012024-01-3108839219ns5:LongLeaseholdAssetsns5:LandBuildings2023-01-3108839219ns5:ComputerEquipment2023-01-3108839219ns5:LongLeaseholdAssetsns5:LandBuildings2024-01-3108839219ns5:ComputerEquipment2024-01-3108839219ns5:LongLeaseholdAssetsns5:LandBuildings2023-01-3108839219ns5:ComputerEquipment2023-01-3108839219ns10:OrdinaryShareClass12024-01-31
REGISTERED NUMBER: 08839219 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 January 2024

for

Health Ink Limited

Health Ink Limited (Registered number: 08839219)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Health Ink Limited

Company Information
for the Year Ended 31 January 2024







DIRECTORS: M MacDonald
J Spavins





REGISTERED OFFICE: Shadwell House
65 Lower Green Road
Rusthall
Tunbridge Wells
TN4 8TW





REGISTERED NUMBER: 08839219 (England and Wales)





ACCOUNTANTS: Peter Hodgson & Co.
Chartered Accountants
Shadwell House
65 Lower Green Road
Tunbridge Wells
Kent
TN4 8TW

Health Ink Limited (Registered number: 08839219)

Statement of Financial Position
31 January 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 6,162 8,216

CURRENT ASSETS
Debtors 5 14,116 3,933
Cash at bank 44,180 59,494
58,296 63,427
CREDITORS
Amounts falling due within one year 6 43,114 36,485
NET CURRENT ASSETS 15,182 26,942
TOTAL ASSETS LESS CURRENT
LIABILITIES

21,344

35,158

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 21,244 35,058
SHAREHOLDERS' FUNDS 21,344 35,158

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 October 2024 and were signed on its behalf by:





M MacDonald - Director


Health Ink Limited (Registered number: 08839219)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

Health Ink Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
There were no significant judgements or estimates pertaining to these accounts.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - 10% on cost
Computer equipment - 3 years

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Functional currency
The company's functional currency is £ Sterling.

Financial instruments
Financial instruments including cash and bank balances are disclosed at fair value.

Health Ink Limited (Registered number: 08839219)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Long Computer
leasehold equipment Totals
£    £    £   
COST
At 1 February 2023
and 31 January 2024 10,867 11,041 21,908
DEPRECIATION
At 1 February 2023 6,520 7,172 13,692
Charge for year 1,087 967 2,054
At 31 January 2024 7,607 8,139 15,746
NET BOOK VALUE
At 31 January 2024 3,260 2,902 6,162
At 31 January 2023 4,347 3,869 8,216

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 14,116 3,933

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Tax 4,604 7,373
Social security and other taxes 4,605 943
Directors' current accounts 32,203 26,930
Accrued expenses 1,702 1,239
43,114 36,485

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary 1 100 100